90:
Crioestaminal invests a significant share of its revenues in R&D projects. The projects aim to develop stem cell-based therapies to further expand the number the clinical applications of cord blood and tissue. It has built a network of partnerships with local institutions such as , and the Centro
27:
and one of the five largest cryo-preservation banks in Europe with over 60,000 stored samples. Crioestaminal was the first company to be authorized by the
Portuguese Ministry of Health and is the only family bank with an
94:
In 2012, Crioestaminal received its first patent for a technology based on cord blood stem cells. The invention is a formulation containing a gel and cord blood stem cells that can be used to treat chronic wounds in
64:
In 2009, The
Riverside Group became the company’s main shareholder. During the last years, the US investment company has contributed to Crioestaminal’s growth in Portugal and abroad.
201:
206:
216:
99:. The investigation was led by Lino Ferreira, a scientist from the Centro de Neurociências e Biologia Celular da Universidade de Coimbra.
57:
In 2007, Crioestaminal released a first sample to be used in a transplant. The cord blood stem cells were used to treat a child with
58:
211:
74:
In 2013, Crioestaminal announced a new investment project that will transform the company into the second-largest
183:
172:
126:
137:
78:
in Europe by storage capacity. During the same year, the company won the customer choice award
96:
20:
50:
During the same year, Crioestaminal founded a company focused molecular biology diagnostics:
32:
accreditation in
Portugal. In Europe, there are only five banks with an AABB accreditation.
149:
75:
40:
Crioestaminal was founded by a group of scientists and health care professionals in 2003.
184:
Seminário - Inhibition of DPP-IV: a new therapeutic approach for diabetic retinopathy?
195:
71:, a Spanish company, in 2010 to strengthen its presence in the neighboring country.
44:
61:. The sample belonged to the child’s sibling and had been stored since 2003.
19:, was founded in 2003, becoming the first umbilical cord blood bank in the
24:
173:
Centro de
Neurociências e Biologia Celular da Universidade de Coimbra
43:
In 2006, Crioestaminal opened its state-of-the-art laboratory in the
29:
115:
23:. Since then, it has developed into the largest
47:, Portugal's first biotechnology science park.
8:
202:Biotechnology companies established in 2003
76:cord blood and tissue cryopreservation bank
127:AABB - American Association of Blood Banks
30:AABB (American Association of Blood Banks)
108:
59:Severe combined immunodeficiency (SCID)
116:Crioestaminal - Saúde e Tecnologia, SA
17:Crioestaminal - Saúde e Tecnologia, SA
7:
207:Biotechnology companies of Portugal
91:de Histocompatibilidade do Centro.
14:
217:2003 establishments in Portugal
52:Genelab – Diagnóstico Molecular
1:
138:Official website of Celvitae
233:
150:"Discovery is in our DNA"
86:Research and development
67:Crioestaminal acquired
80:Escolha do Consumidor
212:Portuguese brands
97:diabetic patients
21:Iberian Peninsula
224:
186:
181:
175:
170:
164:
163:
161:
159:
154:
146:
140:
135:
129:
124:
118:
113:
232:
231:
227:
226:
225:
223:
222:
221:
192:
191:
190:
189:
182:
178:
171:
167:
157:
155:
152:
148:
147:
143:
136:
132:
125:
121:
114:
110:
105:
88:
38:
12:
11:
5:
230:
228:
220:
219:
214:
209:
204:
194:
193:
188:
187:
176:
165:
141:
130:
119:
107:
106:
104:
101:
87:
84:
37:
34:
13:
10:
9:
6:
4:
3:
2:
229:
218:
215:
213:
210:
208:
205:
203:
200:
199:
197:
185:
180:
177:
174:
169:
166:
151:
145:
142:
139:
134:
131:
128:
123:
120:
117:
112:
109:
102:
100:
98:
92:
85:
83:
81:
77:
72:
70:
65:
62:
60:
55:
53:
48:
46:
41:
35:
33:
31:
26:
22:
18:
179:
168:
156:. Retrieved
144:
133:
122:
111:
93:
89:
79:
73:
68:
66:
63:
56:
51:
49:
45:Biocant Park
42:
39:
16:
15:
196:Categories
103:References
25:Portuguese
69:Celvitae
36:History
158:18 May
153:(PDF)
160:2018
198::
82:.
54:.
162:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.